Symbicort Turbuhaler 60MD is a combination inhaled corticosteroid and long-acting beta2-agonist (ICS/LABA) designed for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It delivers consistent bronchodilation and anti-inflammatory action directly to the lungs, reducing exacerbation frequency and improving daily symptom control. This dry powder inhaler is engineered for patient convenience and reliable dosing accuracy, making it a cornerstone therapy in respiratory management.

Features

• Contains budesonide (corticosteroid) and formoterol (bronchodilator) in a single inhaler
• Delivers 60 metered doses per device
• Dry powder formulation, no propellants required
• Dose counter to track remaining inhalations
• Preloaded, multidose design—no priming needed between uses
• Operates at low inspiratory flow rates (≥30 L/min)

Benefits

• Provides dual-action therapy: reduces airway inflammation and relaxes bronchial muscles
• Decreases frequency and severity of asthma and COPD exacerbations
• Improves lung function and overall quality of life
• Enables rapid onset of bronchodilation (within 1–3 minutes)
• Supports adherence through once- or twice-daily dosing flexibility
• Reduces reliance on rescue inhalers when used consistently

Common use

Symbicort Turbuhaler 60MD is indicated for the regular maintenance treatment of asthma in adults and adolescents (12 years and older) and for symptomatic management of COPD, including chronic bronchitis and emphysema, in adults. It is not intended for immediate relief of acute bronchospasm.

Dosage and direction

For asthma: 1–2 inhalations twice daily. Maximum dose: 4 inhalations per day.
For COPD: 2 inhalations twice daily.
Shake well before use. Breathe out fully away from the mouthpiece. Place lips firmly around mouthpiece and inhale deeply and forcefully. Hold breath for 5–10 seconds. Rinse mouth with water after each use to reduce risk of oral candidiasis. Do not exceed prescribed dosage.

Precautions

• Not for relief of acute symptoms; always keep a separate fast-acting bronchodilator available
• Monitor for signs of systemic corticosteroid effects with long-term use (e.g., adrenal suppression)
• Caution in patients with cardiovascular disorders, diabetes, hypokalemia, or thyrotoxicosis
• May mask signs of infection; monitor closely in cases of active or quiescent tuberculosis, fungal or viral infections
• Use during pregnancy only if clearly needed; discuss risks with a healthcare provider

Contraindications

• Hypersensitivity to budesonide, formoterol, or any ingredient in the formulation
• Primary treatment of status asthmaticus or other acute episodes where intensive measures are required

Possible side effects

Common: headache, throat irritation, hoarseness, oral candidiasis, cough.
Less common: palpitations, tremor, nervousness, muscle cramps, nausea.
Rare: paradoxical bronchospasm, tachycardia, hypokalemia, hyperglycemia, adrenal suppression, growth suppression in children.
Seek medical attention if experiencing chest pain, increased breathlessness, or severe allergic reactions.

Drug interaction

• Concomitant use with other beta-adrenergic drugs may potentiate sympathetic effects
• Ketoconazole, itraconazole, or other CYP3A4 inhibitors may increase budesonide exposure
• Diuretics or xanthine derivatives may increase risk of hypokalemia
• Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants may potentiate cardiovascular effects

Missed dose

Take the missed dose as soon as remembered, unless it is nearly time for the next dose. Do not double the dose to make up for a missed one. Resume the regular dosing schedule.

Overdose

Overdose may lead to excessive beta-adrenergic stimulation including angina, hypertension, arrhythmias, nervousness, and headache. Corticosteroid overdose may cause hypercorticism. Symptomatic and supportive treatment is recommended. Cardiac and electrolyte monitoring is advised.

Storage

Store at room temperature (15–30°C) in a dry place. Keep the cap tightly closed when not in use. Do not expose to moisture or extreme temperatures. Discard the device when the dose counter reads “0,” even if it feels like medication remains.

Disclaimer

This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before starting or changing any medication regimen. Individual response to therapy may vary.

Reviews

“Symbicort Turbuhaler has significantly improved my asthma control. The dose counter is helpful, and I appreciate not needing a spacer.” — Maria L., asthma patient
“As a pulmonologist, I find Symbicort 60MD effective for moderate-to-severe asthma and COPD. The combination therapy supports compliance and reduces exacerbations.” — Dr. Evan Rost, MD